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The vaccinia virus O3 protein, a component of the entry–fusion complex, is encoded by all chordopox-
viruses. We constructed truncation mutants and demonstrated that the transmembrane domain, which
comprises two-thirds of this 35 amino acid protein, is necessary and sufﬁcient for interaction with the
entry–fusion complex and function in cell entry. Nevertheless, neither single amino acid substitutions
nor alanine scanning mutagenesis revealed essential amino acids within the transmembrane domain.
Moreover, replication-competent mutant viruses were generated by randomization of 10 amino acids of
the transmembrane domain. Of eight unique viruses, two contained only two amino acids in common
with wild type and the remainder contained one or none within the randomized sequence. Although
these mutant viruses formed normal size plaques, the entry–fusion complex did not co-purify with the
mutant O3 proteins suggesting a less stable interaction. Thus, despite low speciﬁc sequence require-
ments, the transmembrane domain is sufﬁcient for function in entry.
Published by Elsevier Inc.Introduction
Vaccinia virus (VACV) enters cells by fusion either at the plasma
membrane or via a low pH-dependent endosomal mechanism,
depending to some extent on the virus strain (Bengali et al., 2009,
2012; Chang et al., 2010; Huang et al., 2008; Mercer and Helenius,
2008; Mercer et al., 2010; Townsley et al., 2006) and cell type
(Bengali et al., 2009, 2011; Whitbeck et al., 2009). Four proteins
participate in the attachment of mature virions to cell surface
glycosaminoglycans and laminin (Chiu et al., 2007; Chung et al.,
1998; Hsiao et al., 1999; Lin et al., 2000). Twelve proteins that are
conserved in all poxviruses mediate the fusion step, of which
eleven have been shown to associate in a complex (Bisht et al.,
2008; Brown et al., 2006; Izmailyan et al., 2006; Nichols et al.,
2008; Ojeda et al., 2006a, 2006b; Satheshkumar and Moss, 2009;
Senkevich and Moss, 2005; Senkevich et al., 2004, 2005; Townsley
et al., 2005). O3, the subject of the present study, has only 35
amino acids and is the smallest protein with a known function
encoded by VACV (Satheshkumar and Moss, 2009). O3 is a
component of the entry–fusion complex (EFC) and deletion or
repression of O3 results in the production of virus particles that
exhibit a greatly reduced ability to enter cells (Satheshkumar and
Moss, 2009). Although the absence of O3 does not prevent otherInc.
ail.com (B. Moss).components of the EFC from inserting into the MV membrane, the
complex does not form or is unstable under this condition.
The precise roles of the individual proteins comprising the EFC
have not yet been elucidated. However, nine of the eleven EFC
proteins including O3 are required for the initial hemi-fusion step
in entry (Laliberte et al., 2011). Although the amino acid sequence
of O3 is highly conserved among orthopoxviruses, the sequences
are extremely divergent between chordopoxvirus genera. Com-
mon features of all O3 homologs are their location in the genome,
small size and presence of a N-terminal hydrophobic domain.
Despite sequence diversity, O3 homologs from other genera are
able to complement a VACV null mutant (Satheshkumar and Moss,
2012). In VACV, the predicted α-helical TM domain comprises two-
thirds of the 35-amino acid O3 protein. Preliminary evidence that
the TM domain determines O3 function was obtained by swapping
the N-terminal TM and C-terminal domains of O3 with the
corresponding domains of an unrelated VACV EFC protein
(Satheshkumar and Moss, 2012). The chimeric protein, which
retained the O3 TM domain, complemented an O3 null mutant
and interacted with other EFC proteins, whereas the chimeric
protein that retained the C-terminal domain of O3 was non-
functional. These data suggested that the O3 TM domain interacts
with other EFC proteins possibly through their membrane-
spanning domains. The purpose of the present study was to
directly determine whether the TM domain is sufﬁcient for O3
function and to interrogate the sequence requirements of this
domain.
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Effect of O3 truncations on trans-complementation
of an O3 null mutant
The N-terminal 22 amino acids of O3 are predicted to include
the α-helical TM domain, which is followed by a 13 amino acid
external domain that starts with a conserved positively chargedFig. 1. Trans-complementation by O3-truncation mutants. (A) The predicted
sequence of the WT O3 ORF (N-35) and progressive C-terminal truncation mutants
(N-24 to N-17). Tag refers to the nine amino HA sequence appended to the
C-terminus of each protein. The predicted TM domain from position 4 to 22 is in
bold. (B) Complementation activity. BS-C-1 cells were infected with vO3-HAi-LUC
in the presence (+) or absence (−) of IPTG and in the latter case transfected with a
control topoisomerase plasmid (TOPO) or with a plasmid encoding full length (N-
35) or a truncated (N-24 to N-17) O3 protein. Relative virus yields were determined
by a LUC-based entry assay. RLU/s (relative light unit per second). (C) Western blots
of cells infected and transfected as in panel B. The blots were probed with
antibodies to the HA tag on O3 mutants, the VACV A11 protein as a viral loading
control, and cellular glyceraldehyde-3-phosphate dehydrogenase (GAPDH) as a
cellular loading control.amino acid followed by proline. We constructed a series of
truncation mutants in which the C-terminus of O3 was replaced
by a 9-amino acid HA tag (Fig. 1A). The abilities of these constructs
to trans-complement the O3 null mutant vO3-HAi-LUC, which
contains an inducible O3 with an HA epitope tag at the C-terminus
as well as the luciferase (LUC) gene regulated by a VACV promoter,
were tested using a two-step protocol (Satheshkumar and Moss,
2012). First, BS-C-1 cells were infected with vO3-HAi-LUC in the
absence of inducer to prevent O3 synthesis and transfected with a
control plasmid or plasmid encoding a truncated O3 under the
natural O3 promoter. Use of the natural promoter ensured that
transcription would take place in the virus factory. The cells were
harvested after 24 h and the lysates were used to infect fresh cells.
After 1 h, LUC activity was determined as a measure of entry-
competent virus in the lysate from the ﬁrst step. With lysates from
untransfected cells that were infected with vO3-HAi-LUC in the
absence and presence of inducer, there was about a 2-log differ-
ence in LUC activity (Fig. 1B). The LUC activity declined further in
cells infected with vO3-HAi-LUC in the absence of inducer and
transfected with the control TOPO plasmid, probably due to some
reagent toxicity. Transfection of the WT O3 plasmid (N-35)
restored more than a log of LUC activity relative to untransfected
cells infected with vO3-HAi-LUC in the absence of inducer
(Fig. 1B), indicating the formation of infectious virus. About 60%
of the activity, relative to N-35, was obtained by transfection of the
N-24 truncation mutant, which retained the TM as well as the
conserved positively charged amino acid followed by proline
(Fig. 1B). Activity decreased to about 40% and 20% of the WT value
with deletions of the proline (N-23) and arginine (N-22), respec-
tively. With removal of additional amino acids, the LUC activities
were in the range of 10–20% of WT until N-17, at which no activity
above the control was detected (Fig. 1B). Western blotting indi-
cated that the amounts of N-24 to N-21 proteins were similar to
WT but that the amounts decreased with greater truncations
(Fig. 1C).
Construction and analysis of viruses with C-terminal truncations
of O3
The above transfection experiments demonstrated that the TM
domain with the two additional conserved amino acids (N-24) was
sufﬁcient for signiﬁcant O3 function but that N-17 had little or no
activity. To conﬁrm these results in the context of a virus,
recombinant VACV were constructed with WT N-35 and the
truncation mutants N-24 and N-17 by replacing GFP in vO3Δ
(Fig. 2A). DsRED under a separate promoter was co-inserted in
order to facilitate virus isolation. The plaque size of the N-35 virus
was similar to that of the parental VACV strain WR suggesting that
the DsRED and the HA epitope tag had no appreciable effect on
virus replication and spread (Fig. 2B). The N-24 virus also formed
WT-size plaques, conﬁrming the sufﬁciency of the shortened ORF.
However, the N-17 virus, with a truncated TM, formed tiny plaques
similar to those of the O3 deletion virus.
Next we checked whether the mutated O3 proteins were
incorporated into MVs. The virus particles were puriﬁed by
sucrose gradient sedimentation and analyzed by Western blotting
using antibody to the HA tag. Both mutant proteins were detected
in virions, although the N-17 was present in a low amount
(Fig. 2C). We also determined the ability of the mutated O3
proteins to interact with other VACV EFC proteins. Our previous
afﬁnity puriﬁcation studies showed stable association of O3 with
the EFC. Here, we used the HA tag attached to the O3 proteins to
co-purify associated proteins from infected cell lysates and per-
formed Western blotting with antibodies to two representative
EFC proteins L5 and A16. As a negative control, we incubated
lysates from cells infected with the parental VACVWR, which lacks
Fig. 2. Characterization of recombinant VACV encoding mutant O3 proteins. (A) Diagram of recombinant viruses. vO3 mutant viruses were constructed by replacing GFP of
vO3Δ with full length (N-35) or truncated (N-24 or N-17) O3 ORF and a DsRed ORF regulated by a VACV promoter. Arrows indicate the direction of transcription of indicated
ORFs. vWR, parental VACV strain WR. (B) Plaque formation. Revertant viruses were isolated by picking red ﬂuorescent plaques and clonally puriﬁed. Appropriate dilutions of
indicated viruses were applied to BS-C-1 monolayers, covered with methylcellulose and incubated at 37 1C for 2 days. Plaques were visualized by staining with crystal violet.
(C) Western blot of proteins from puriﬁed virus particles. Virus particles were puriﬁed by sedimentation through a sucrose cushion and banding on a sucrose gradient. Equal
amounts of virus, determined by optical density, were solubilized with SDS and subjected to polyacrylamide gel electrophoresis. The proteins were transferred to a
nitrocellulose membrane and the O3 proteins were detected by staining with antibody to the HA epitope tag. The A3 protein was detected with speciﬁc antibody as a viral
loading control. (D) Association of O3 proteins with the EFC. Infected BS-C-1 cells were lysed with triton X-100 and the O3 proteins were bound to beads coupled with anti-
HA antibody. After washing, the proteins were eluted with SDS and analyzed by Western blotting using antibodies to HA to detect O3 proteins and to speciﬁc antibodies to
two representative EFC proteins L5 and A16. WR represents the parental VACV strain, which has no HA-epitope tag.
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24 O3 proteins but were not detected above the WR background
with the N-17 O3 protein (Fig. 2D). The result obtained with N-24
conﬁrmed our idea that the interaction of O3 with other EFC
proteins occurs through the TM domain.
Site-directed mutagenesis
The effects of truncation mutants could be due to a combina-
tion of removal of speciﬁc amino acids and progressive shortening
of the expressed protein. To evaluate the sequence effects speci-
ﬁcally, we made amino acid substitution mutations within the TM
domain of the full length O3 protein. The selection of amino acids
to mutate was made by identifying the most conserved amino
acids in O3 homologs of other chordopoxviruses. As depicted in
Fig. 3A, the N-terminal 24 amino acids of the O3 homologs of
representatives of chordopoxvirus genera are diverse in sequence,
although there is an enrichment of hydrophobic amino acids.
Indeed, there are no completely conserved amino acids within the
TM domain, which is predicted to be between amino acids 4–22.
Highly or moderately conserved amino acids included the bulky
hydrophobic amino acid phenylalanine at positions 7 and 11,
cysteine at position 14, hydroxyl side chain amino acids serine
and tyrosine at positions 18 and 19, respectively, and a leucine at
position 22. The following substitutions in the above amino acids
were made: F7A, F11A, C14A, S18A and the SYSY to AFAF in a N-35
O3 ORF containing a C-terminal HA tag that was regulated by thenatural O3 promoter (Fig. 3B). The effects of these mutations were
evaluated by transfecting plasmids expressing the mutated ORFs
into cells infected with vO3-HAi-LUC in the absence of inducer.
Remarkably, there was little or no effect on the virus yields as
measured by LUC activity (Fig. 3C) or protein expression deter-
mined by Western blotting (Fig. 3D).
Secondary structure predictions suggested the presence of an
α-helix within the TM domain of O3. An O3 mutant was con-
structed by adding two alanines, which have high helix propensity,
within the α-helix (Fig. 3B). Since looping out of residues should be
disfavored in a lipid environment, the consequence could be to
displace amino acids and alter geometry and hydrogen bonding.
The mutated O3 protein was expressed at WT level (Fig. 3D) but
complementation ability was reduced by about 80% (Fig. 3C),
consistent with a structural perturbation. Single proline insertions
at positions 8 or 13 or a double mutation at both positions were
made in order to break the predicted α-helix. Although these
mutations almost completely abrogated complementation, the
proteins could not be detected by Western blotting even when
the proteasome inhibitor MIG132 was added (data not shown).
Therefore, we could not interpret the effects of these proline
insertions on O3 function.
In addition to making mutations within the predicted TM
domain, we also made alanine substitutions of the conserved
positively charged amino acid and proline, at positions 23 and 24,
respectively (Fig. 4A). These mutations were made in the N-24
truncation mutant. The mutated protein was stably expressed and
Fig. 3. Site-speciﬁc mutations within the TM domain. (A) Sequences of O3
homologs. The N-terminal 24 amino acids of representative chordopoxvirus O3
homologs are shown. Relatively conserved amino acids are shaded and shown at
the bottom. Abbreviations: YMTV, Yaba monkey tumor virus; SWPV, swinepox
virus; SPPV, sheeppox virus; ORV, orf virus; MYXV, myxoma virus; FWPV, fowlpox
virus. (B) Site-speciﬁc mutations within the full-length N-35 O3 protein. Alanine
substitutions and addition shown in bold. C-terminal HA tag indicated. (C) Effects
of site-speciﬁc mutations on complementation of O3 null mutant. BS-C-1 cells were
infected with vO3-HAi-LUC in the presence (+) or absence (−) of IPTG and the latter
were transfected with TOPO control plasmid or plasmid containing mutated O3
ORFs indicated in panel B. Complementation was assayed as in Fig. 1B. (D) Western
blots of transfected cells probed with antibody to HA to detect O3 proteins and
with speciﬁc antibodies to the VACV control A11 and the cell control GAPDH.
Fig. 4. Mutations of the two amino acids following the TM domain. (A) Sequences
of full length N-35 O3 ORF, truncated N-24 O3 ORF and truncated N-24 ORF with
alanine substitutions. The putative TM domain is in bold letters. (B) BS-C-1 cells
were infected with vO3-HAi-LUC in the presence (+) or absence (−) of IPTG and the
latter were transfected with control TOPO plasmid or plasmids indicated in panel A.
Complementation assays were carried out as in Fig. 1B. (C) Western blot of lysates
of cells infected with vO3-HAi-LUC and transfected as in panel B. The Western blot
was probed with antibody to the HA tag to detect O3 proteins and to A11 as a virus
loading control.
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N-24 control (Fig. 4B, C). Thus, none of the mutations of conserved
amino acids had a major effect on the function of O3.Alanine-scanning mutation of TM domain
Since changes of individual conserved amino acids did not
affect O3 function, we made more drastic alanine-scanning muta-
tions. Groups of four consecutive amino acid residues, from
positions 2 to 17, were mutated to alanine (Fig. 5A). Surprisingly,
none of these mutations had a signiﬁcant impact on O3 comple-
mentation ability (Fig. 5B). We also made a plasmid containing the
O3 ORF in which each amino acid from position 7 to 16 was
changed to alanine. Although this mutant was unable to comple-
ment vO3-HAi-LUC, the protein could not be detected by Western
blotting precluding as assessment of O3 function (data not shown).
Randomization of the O3 TM domain sequence
Since neither alanine substitutions of individual conserved
amino acids nor four-amino acid alanine scanning mutations of
O3 had much effect on the ability to complement an O3 null
mutant, we took another approach to determine the limits of
sequence ﬂexibility. As we knew that substitution of the amino
acids 7–16 with alanines resulted in loss of stability and function,
we made a panel of recombinant viruses with those 10 amino
Fig. 5. Alanine scanning mutations. (A) Diagram of sites of AAAA substitutions in
O3. The substitutions are indicated in bold. (B) Complementation. Infection,
transfection and complementation were determined as in Fig. 1B.
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tion of plaque size. A chemically-synthesized degenerate codon
library of 30 nucleotides, in which there was an enrichment of
hydrophobic amino acid codons (Marlatt et al., 2011), was ﬂanked
by the remaining N- and C-terminal O3 and neighboring
sequences (Fig. 6A). Homologous recombination was achieved by
transfecting the library into BS-C-1 cells that had been infected
with vO3Δ, a VACV deletion mutant in which GFP had replaced O3.
After ﬁve serial passages, to enrich for recombinant viruses that
replicated better than the parental vO3Δ, a plaque assay was
performed. Viruses were isolated from 39 large, non-ﬂuorescent
plaques and clonally puriﬁed. There were eight unique O3
sequences in the 39 isolates. The plaque sizes of the eight were
similar to those of WT virus and larger than the deletion mutant
(Fig. 6B). Although hydrophobic amino acids were enriched, three
of the mutants (d23, d19, d7) shared no amino acids with WT,
three of the mutants (d25, d10, d8) shared one amino acid and two
(d22, d20) shared two amino acids (Fig. 5C). The most common
amino acids shared with WT were the phenylalanines at positions
7 and 13. Interestingly, four of the mutants (d22, d20, d19. d10)
had potential helix breakers: a glycine in three cases and a proline
in one. In three of these mutants, the glycine or proline was at the
position of a bulky hydrophobic amino acid in WT O3.
We also clonally isolated and characterized virus from one
small, white plaque (S10) that was similar in size to the deletion
mutant (Fig. 7A). The sequence differed from WT in lacking any
bulky hydrophobic residues (Fig. 7C). However, one of the large
plaque isolates (d19) also lacked bulky hydrophobic amino acids.Western blot of the lysate indicated that the S10 O3 protein was
present in amounts similar to that of WT O3 and the large plaque
mutant d19 (Fig. 7B). Therefore the small plaque was not due to
instability of the O3 protein.
Properties of viruses with randomized O3 sequences
The viruses from the randomized sequence screen were pur-
iﬁed from infected cells by sucrose-density gradient centrifugation
to determine whether the mutated O3 proteins were incorporated
into the MV membrane like WT O3. Western blot analysis
demonstrated that the modiﬁed O3 proteins of the small plaque
isolate (Fig. 7D) as well as the large plaque isolate (Fig. 8A) were
indeed present in puriﬁed virions and could be extracted with
non-ionic detergent, indicating membrane association. Next we
investigated whether the mutated O3 proteins, like WT O3,
formed a stable interaction with proteins in the EFC. When the
WT O3 protein was afﬁnity puriﬁed, three representative compo-
nents of the EFC were detected by Western blotting (Fig. 8B).
However, the EFC proteins did not detectably co-purify with the
O3 proteins with randomized sequences (Fig. 8B), despite the
ability of the latter to functionally replace O3. These results were
reminiscent of a previous ﬁnding that the Orf virus sequence
divergent O3 homolog could complement O3 for VACV replication
but did not pull down EFC proteins in a similar assay
(Satheshkumar and Moss, 2012).
We also checked the ability of the viruses with randomized O3
sequences to mediate cell–cell fusion at low pH, which had
previously been shown to require O3 (Satheshkumar and Moss,
2009). Like WT, none of the mutants acquired the ability to
mediate syncytium formation at neutral pH and most triggered
fusion at low pH (Fig. 9). Two mutants that induced few syncytia
were vO3-d22 and vO3-d20, although their plaques were similar
in size to WT O3.Discussion
The O3 protein, despite its small size, is a bona ﬁde component
of the EFC: it associates with the MV membrane, is required for
entry and low pH triggered cell–cell fusion, stably interacts with
other components of the EFC, and is required for EFC assembly and
stability (Satheshkumar and Moss, 2009). Several previous obser-
vations had suggested a speciﬁc role of the TM domain of O3. First,
the TM domain was predicted to comprise two-thirds of this 35
amino acid protein (Satheshkumar and Moss, 2009). Second, the
external domains of O3 homologs varied in length, with some
even shorter than the VACV O3, and had no signiﬁcant sequence
homology. Third, in a domain swapping experiment between O3
and the A21 EFC protein, a chimera containing the O3 TM and a
shortened A21 C-terminal domain could complement an O3 null
mutant, whereas the opposite, i.e. a chimera with the A21 TM and
the O3 C-terminal domain, could not (Satheshkumar and Moss,
2012). Here, we have shown directly that the ﬁrst 22–24 amino
acids of O3 are sufﬁcient for complementation of an O3 null
mutant. Like WT O3, the 24 amino acid protein was inserted into
the MV membrane and interacted with other protein components
of the EFC.
In view of the evidence for the importance of the TM domain
for O3 function, the abilities of sequence divergent TM domains
from different chordopoxvirus genera to functionally complement
a VACV O3 null mutant is surprising (Satheshkumar and Moss,
2012). Multiple sequence analysis of TM domains of O3 homologs
did not reveal highly conserved features, although there was
modest conservation of large bulky hydrophobic amino acids.
Substitutions of the individual most conserved amino acids in
Fig. 6. Isolation of large plaque-forming mutants with randomized TM sequences. (A) Diagram of region of O3 subjected to randomization. Upper: Diagrams of WT O3 and
randomized O3 sequences. The randomized amino acids are indicated by Xs. Lower: Diagrams of region of vO3Δ genome showing O3 ORF replaced by GFP and revertant
viruses containing randomized O3. (B) Plaque formation. BS-C-1 cells were infected with vO3Δ and transfected with a library of randomized O3 sequences containing HA tag.
After ﬁve consecutive passages, 39 large non-ﬂuorescent plaques were clonally puriﬁed and the O3 ORF was sequenced. Eight of the large plaque-forming viruses (d7, d8,
d10, d19, d20, d22, d23 and d25) had unique sequences. Plaques formed by the parent vO3Δ, vO3-HA WT, and mutants. BS-C-1 monolayers were infected, covered with
methylcellulose and incubated at 37 1C for 2 days. Plaques were visualized by staining with crystal violet. (C) Comparison of O3 sequences from amino acid 7 to 16 of WT and
mutants. Amino acids repeated in multiple isolates are shaded.
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unusual four consecutive hydroxyl-group containing amino acids
(SYSY) with AFAF failed to signiﬁcantly reduce the complementa-
tion efﬁciency of O3. There was also little effect of substituting the
conserved positively charged amino acid and proline following the
TM domain with alanines. Even replacing four amino acids at a
time by alanine scanning did not appreciably affect O3 function.
However, adding rather than replacing two alanines within the TM
domain, which should alter the geometry and hydrogen-bonding,
reduced complementation appreciably.
To explore permissible amino acids within the TM domain, we
chemically synthesized degenerative codon libraries to replace all
or part of the WT TM domain of O3 and screened for viruses that
made WT-size plaques. Because the fully randomized sequence
space derived from 10 positions with codons for all 20 amino acids
would require impossible screening of 1015 members (Mena and
Daugherty, 2005), we made a library that was biased for hydro-
phobic amino acids (Marlatt et al., 2011). This library replaced the
10 amino acids from residues 7 to 16 of O3. DNA containing the
mutated O3 ORF was transfected into cells infected with an O3
deletion mutant and the progeny were passaged multiple times toselect viruses with enhanced replication. The latter were then
screened by plaque formation and viruses from 39 “WT-like”
plaques were isolated. Eight of these isolates had unique
sequences. Remarkably, three of the mutants shared no rando-
mized amino acids with the WT O3 sequence, three shared one
amino acid and two shared two amino acids. Moreover, the
mutants had few randomized amino acids in common with each
other, suggesting a very large degree of plasticity of the O3 TM
domain. Interestingly, a potential helix-breaking glycine at posi-
tions 8, 11 or 15 or a proline at position 11 was found in four WT-
like O3 mutants. In contrast, the speciﬁc insertion of a proline at
position 8 or 13 into the WT O3 sequence resulted in instability of
the O3 protein indicating the importance of sequence context. In
an additional, admittedly high-risk experiment, we made a 21-
codon hydrophobic amino acid biased library encompassing the
entire TM domain of O3 hoping that the permitted sequence
diversity would allow isolation of some totally random O3
sequence mutants with wild type size plaques. However, the
sequence space of a degenerative library increases exponentially
with each additional residue and it was not too surprising that we
failed to isolate WT-like virus (data not shown).
Fig. 7. Isolation of small plaque-forming mutant with randomized TM sequence. (A) Plaque formation by mutant virus. Procedures as in Fig. 6B except virus was isolated
from a small non-ﬂuorescent plaque and clonally puriﬁed. Image shows crystal violet stained plaques that formed after 3 days to better view the small S10 plaques. (B) Cell
lysates from cells infected with vO3-HAWT, small plaque mutant S10 or large plaque mutant d19 were analyzed byWestern blotting and probed with antibody to the HA tag
on O3 or speciﬁc antibody to A11 as a viral protein loading control. (C) Comparison of O3 sequences from amino acid 7 to 16 of WT and mutant. Amino acid repeated in
mutant and WT is shaded. (D) Association of O3 mutant protein with puriﬁed virus particles. Virus particles were puriﬁed from infected cell lysates by sedimentation
through a sucrose cushion and banding on a sucrose gradient. Equal amounts of puriﬁed virus determined by optical density were incubated with buffer containing NP-40
and centrifuged to separate the solubilized membrane proteins (S) and the pelleted core proteins (P).
Fig. 8. Properties of O3 large plaque randomization mutants. (A) Association of O3 proteins with puriﬁed virus particles. Virus particles were puriﬁed from infected cell
lysates by sedimentation through a sucrose cushion and banding on a sucrose gradient. Equal amounts of puriﬁed virus determined by optical density were incubated with
buffer containing NP-40 and centrifuged to separate the solubilized membrane proteins (S) and the pelleted core proteins (P). The proteins from both fractions were analyzed
by SDS polyacrylamide gel electrophoresis and Western blotting with antibodies to HA to detect O3. Antibodies to L1 and A3 were used to visualize a membrane and core
protein, respectively. (B) Afﬁnity puriﬁcation of EFC proteins. Infected BS-C-1 cells were lysed with triton X-100 and the O3 proteins were bound to beads coupled with anti-
HA antibody. After washing, the proteins were eluted with SDS and analyzed by Western blotting using antibodies to HA to detect O3 proteins and to speciﬁc antibodies to
three representative EFC proteins L5, A16 and A28. WR represents the parental VACV strain with no HA-epitope tag; WT represents virus with the WT O3 containing an HA
epitope tag. Western blots of the extract prior to afﬁnity puriﬁcation (Input) and after HA afﬁnity puriﬁcation (HA afﬁnity precipitation) are shown.
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complex was obtained by afﬁnity isolation of representative EFC
proteins by both the wild type O3 and the N-terminal 24-amino
acid truncation mutant. We considered that mutations within the
TM domain might have a subtle effect on the O3 interaction with
the EFC that was not revealed by plaque size. With this in mind,we performed afﬁnity isolations with the TM randomization
mutants. Although the mutant O3 proteins were incorporated into
the virion membrane, EFC proteins did not co-purify with them. In
view of the ability of these mutant viruses to mediate virus
infection, large plaque formation and cell–cell fusion, we suggest
that the interaction of the O3 TM domain with the EFC is functional
Fig. 9. Abilities of O3 randomization mutants to mediate cell–cell fusion. BS-C-1 cells were infected with vO3-WT or randomized O3 mutant viruses with HA epitope tag. After 16 h,
the cells were brieﬂy incubated with medium at pH 5.5 or 7.4 at 37 1C. Cells were incubated in regular medium for 2 additional hours and viewed by light microscopy.
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to an antibody afﬁnity column and stringent washing. However, an
alternative explanation is that the association of O3 with other EFC
components is not necessary for function.
Virus entry and syncytium formation require EFC proteins and
likely employ a similar mechanism of membrane fusion (Wagenaar
and Moss, 2007). Nevertheless, there are signiﬁcant differences. While
a single virus particle can fuse with the cell membrane, hundreds of
particles are necessary to demonstrate syncytium formation. Further-
more, virus particles can fuse with the plasma membrane at neutral
pH whereas a low pH pulse is needed for MVs to mediate cell–cell
fusion. Cell–cell fusion may require multiple fusion events to occur
nearly simultaneously (Moss, 2006). We found that most of the
mutant O3 proteins enabled both cell entry and syncytium formation.
However, two mutants, d20 and d22, were positive in the cell entry
assay but not for syncytium formation. In theory, an inability to
mediate cell–cell fusion could result if d20 and d22 reacted differently
to low pH or had slower fusion kinetics than other mutants. Although
d22 is unusual in having four methionine substitutions and both
mutants have a glycine substitution within the TM, we have no
evidence to show that these sequence changes are consistent with
the above explanations.We embarked on this study with optimism that we would be
able to deﬁne a sequence or structure that accounted for the
speciﬁc requirement of O3 for VACV entry. Although we can
deﬁnitively conclude that the TM domain is necessary and
sufﬁcient, the extremely high degree of sequence ﬂexibility within
the TM domain has prevented us from making a structural model.
Like many studies, the present one opens up a multitude of new
questions such as: how is the 35 amino acid full length O3 protein
and the 24 amino acid truncated version, containing a 9 amino
acid HA tag, transported to the viral membrane; does the TM
domain penetrate through the viral membrane or is part exposed;
does the TM domain interact with the TM domain of other EFC
proteins; and which EFC proteins directly interact with O3?Materials and methods
Cells and viruses
BS-C-1 cells were maintained in minimum essential medium
with Earle's salts supplemented with 10% fetal bovine serum, 100
units of penicillin and 100 mg of streptomycin per ml (Quality
P.S. Satheshkumar et al. / Virology 444 (2013) 148–157156Biologicals, Gaithersburg, MD). The recombinant virus vO3-HAi-
LUC (Satheshkumar and Moss, 2012) and vO3Δ (Satheshkumar
and Moss, 2009) were described previously. Virus particles were
puriﬁed by sedimentation through a 36% sucrose cushion and
banding on 25–40% sucrose density gradient (Earl and Moss, 1998).
Extraction of membrane proteins was carried out as previously
described (Satheshkumar and Moss, 2012).
Trans-complementation assay
Complementation assays were carried out by infecting BS-C-1
cells in four wells of a 12-well plate with vO3-HAi-LUC, transfect-
ing with plasmids encoding O3 mutants, and determining virus
yields at 24 h after infection in three of the wells by a LUC-based
entry assay (Satheshkumar and Moss, 2012). The fourth well was
used for Western blotting to ensure expression of the O3 protein.
For the LUC assay, 0.1 ml of lysate was added to BS-C-1 cells in a
24-well plate, which was incubated for 1 h at room temperature to
allow virus adsorption, washed with medium and incubated in
0.5 ml of medium for 1 h at 37 1C to allow LUC expression. The
cells were lysed with 150 μl of Cell Culture Lysis Reagent (Promega,
Madison, WI) for 15 min at room temperature on an orbital shaker.
Following addition of 20 μl of cell lysate to 100 μl LUC substrate,
LUC activity was measured with a luminometer (Berthold Sirius,
Bad Wilbad, Germany). Preliminary experiments veriﬁed that the
LUC activity was proportional to virus concentration as deter-
mined by plaque assay.
Construction of recombinant viruses with mutated O3 genes
The GFP gene in an O3 deletion virus (vO3Δ) was replaced by
homologous recombination with a mutated O3 ORF regulated by
the O3 promoter and an adjacent DsRED ORF controlled by VACV
P11 late promoter. Red ﬂuorescent plaques were picked repeatedly
and characterized by PCR and sequencing.
Construction of recombinant viruses with randomized O3 TM
sequences
DNA primers with degeneracy at 30 nucleotide positions were
used to randomize the 10 amino acids corresponding to positions
7–16 of the O3 amino acid sequence. To enrich hydrophobic amino
acids, the speciﬁc nucleotide composition was N¼28–28–28–16
(A¼28%; C¼28%; G¼28%; T¼16%), N1¼07–17–07–69 (A¼07%;
C¼17%; G¼07%; T¼69%) and N2¼00–90–10–00 (A¼0%; C¼90%;
G¼10%; T¼0%) at each position of the coding triplet sequence, N,
N1, N2 as described (Marlatt et al., 2011). The degenerate PCR
product was fused with left and right ﬂanking sequences and
transfected into BS-C-1 cells infected with vO3Δ to replace the GFP
ORF with the randomized O3 ORF sequence. After ﬁve consecutive
passages, large plaque-forming viruses without green ﬂuorescence
were identiﬁed and clonally puriﬁed.
Afﬁnity puriﬁcation
Interactions of O3 with other proteins were determined in
infected cells by afﬁnity puriﬁcation with anti-HA antibody afﬁnity
beads (Roche, Indianapolis, IN). Brieﬂy, infected cells were lysed in
50 mM Tris pH 8.0, 200 mM NaCl, 1% triton X-100 buffer contain-
ing complete protease inhibitor tablet (Roche) for 30 min at 4 1C.
Lysates were clariﬁed by centrifugation at 10,000g for 10 min at
4 1C and the supernatant was incubated with anti-HA antibody
beads. After binding and washing, the beads were boiled with 1
lithium dodecyl sulfate loading solution containing dye and
proteins were separated in a 4–12% Bis–Tris gel, transferred to a
nitrocellulose membrane, and probed with speciﬁc antibodies.Cell–cell fusion assay
BS-C-1 cells were infected with WT virus or O3 mutants at a
multiplicity of 3 PFU/cell. After 16 h, the cells were treated with pH
5.0 buffer for 3 min, washed and incubated in fresh medium for
another 2 h. Syncytia were visualized by light microscopy.Acknowledgments
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